Literature DB >> 1864608

Three unique base pair changes in a family with Gaucher disease.

N Eyal1, N Firon, S Wilder, E H Kolodny, M Horowitz.   

Abstract

Single-stranded cDNA was prepared from RNA obtained from a patient with type 1 Gaucher disease. The cDNA was amplified in vitro and analyzed by sequencing. Three base-pair changes were identified which included a G to C transversion at nucleotide 3119 of the active gene (Asp140----His), an A to C transversion at nucleotide 3170 (Lys157----Gln) and a G to A change at nucleotide 5309 (Glu326----Lys). To study the mode of inheritance of the three different base-pair changes, genomic DNA was prepared from blood or skin fibroblasts of several family members. Genomic glucocerebrosidase DNA sequences were amplified and subjected to hybridization with allele-specific oligonucleotides (ASOs). The hybridization profiles demonstrated that two of the base-pair changes originated from the mother and were transmitted to her two affected sons and to a grandchild, while the third base-pair change, originating from the father, was transmitted to his two affected sons, a carrier daughter and a second grandchild. Tests of other patients with Gaucher disease failed to disclose the presence of the three base-changes. This is a unique family with three base-pair changes tightly linked to Gaucher disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864608     DOI: 10.1007/bf00200914

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  32 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  Structural analysis of the human glucocerebrosidase genes.

Authors:  O Reiner; M Wigderson; M Horowitz
Journal:  DNA       Date:  1988-03

3.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

4.  Prenatal diagnosis of beta-thalassemia. Detection of a single nucleotide mutation in DNA.

Authors:  M Pirastu; Y W Kan; A Cao; B J Conner; R L Teplitz; R B Wallace
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

5.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

Authors:  T Latham; G A Grabowski; B D Theophilus; F I Smith
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

6.  A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.

Authors:  A Zimran; J Sorge; E Gross; M Kubitz; C West; E Beutler
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies.

Authors:  R A Barneveld; W Keijzer; F P Tegelaers; E I Ginns; A Geurts van Kessel; R O Brady; J A Barranger; J M Tager; H Galjaard; A Westerveld; A J Reuser
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.

Authors:  T Dinur; K M Osiecki; G Legler; S Gatt; R J Desnick; G A Grabowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.

Authors:  S S Raghavan; J Topol; E H Kolodny
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

10.  Assignment of the gene for acid beta-glucosidase to human chromosome 1.

Authors:  B Shafit-Zagardo; E A Devine; M Smith; F Arredondo-Vega; R J Desnick
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

View more
  8 in total

1.  Neuronopathic and non-neuronopathic presentation of Gaucher disease in patients with the third most common mutation (D409H) in Spain.

Authors:  A Chabás; B Cormand; S Balcells; R González-Duarte; C Casanova; J Colomer; L Vilageliu; D Grinberg
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  A mutation in SCARB2 is a modifier in Gaucher disease.

Authors:  Arash Velayati; John DePaolo; Nidhi Gupta; Jae H Choi; Nima Moaven; Wendy Westbroek; Ozlem Goker-Alpan; Ehud Goldin; Barbara K Stubblefield; Edwin Kolodny; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2011-09-15       Impact factor: 4.878

4.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Authors:  M E Grace; P Ashton-Prolla; G M Pastores; A Soni; R J Desnick
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Glucocerebrosidase mutations in Gaucher disease.

Authors:  E Beutler; A Demina; T Gelbart
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

6.  Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level.

Authors:  O Amaral; A M Fortuna; L Lacerda; R Pinto; M C Sa Miranda
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

7.  Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.

Authors:  Tim E Moors; Silvia Paciotti; Angela Ingrassia; Marialuisa Quadri; Guido Breedveld; Anna Tasegian; Davide Chiasserini; Paolo Eusebi; Gonzalo Duran-Pacheco; Thomas Kremer; Paolo Calabresi; Vincenzo Bonifati; Lucilla Parnetti; Tommaso Beccari; Wilma D J van de Berg
Journal:  Mol Neurobiol       Date:  2018-06-08       Impact factor: 5.590

8.  A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.

Authors:  Jonas M den Heijer; Valerie C Cullen; Marialuisa Quadri; Arnoud Schmitz; Dana C Hilt; Peter Lansbury; Henk W Berendse; Wilma D J van de Berg; Rob M A de Bie; Jeffrey M Boertien; Agnita J W Boon; M Fiorella Contarino; Jacobus J van Hilten; Jorrit I Hoff; Tom van Mierlo; Alex G Munts; Anne A van der Plas; Mirthe M Ponsen; Frank Baas; Danielle Majoor-Krakauer; Vincenzo Bonifati; Teus van Laar; Geert J Groeneveld
Journal:  Mov Disord       Date:  2020-07-02       Impact factor: 10.338

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.